Australia Neurosurgery Market – Industry Trends and Forecast to 2032

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE AUSTRALIA NEUROSURGERY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET END USER COVERAGE GRID

2.1 DBMR VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.2 PESTEL ANALYSIS

4.3 HEALTHCARE EXPENDITURE WITH A FOCUS ON NEUROSURGERY

4.3.1 PROCEDURES

4.3.2 ENDARTERECTOMY (REMOVAL ARTERY LINING BLOCKAGE)

4.4 NEUROSURGERY VOLUME TREND

4.5 EPIDEMIOLOGY

5 AUSTRALIA NEUROSURGERY MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TECHNOLOGICAL ADVANCEMENTS IN NEUROSURGICAL PROCESSES

6.1.2 RESEARCH AND INNOVATION IN NEUROSCIENCE

6.1.3 RISE IN AGING POPULATION

6.1.4 GOVERNMENT POLICIES SUPPORTING PUBLIC HEALTH

6.2 RESTRAINTS

6.2.1 LIMITED ACCESS TO HEALTHCARE IN RURAL AREAS

6.2.2 CONCERNS ASSOCIATED WITH POST-SURGICAL COMPLICATIONS

6.3 OPPORTUNITIES

6.3.1 RISING ADOPTION OF TELEMEDICINE

6.3.2 RISE IN INNOVATIVE TREATMENT OPTIONS

6.3.3 INCREASE IN THE NUMBER OF COLLABORATIONS AND PARTNERSHIPS AMONG UNIVERSITIES AND HOSPITALS

6.4 CHALLENGES

6.4.1 SHORTAGE OF QUALIFIED NEUROSURGEONS

6.4.2 HIGH COSTS ASSOCIATED WITH NEUROSURGICAL TRAINING

7 AUSTRALIA NEUROSURGERY MARKET, BY APPLICATION

7.1 OVERVIEW

7.2 TRAUMA SURGERY

7.2.1 TRAUMATIC BRAIN SURGERY

7.2.2 SPINAL CORD INJURY

7.3 SPINAL NEUROSURGERY

7.3.1 DEGENERATIVE SPINAL DISORDERS

7.3.2 SPINAL TUMORS

7.4 TUMOR RESECTION

7.4.1 PRIMARY BRAIN TUMORS

7.4.2 METASTATIC BRAIN TUMORS

7.5 VASCULAR SURGERY

8 AUSTRALIA NEUROSURGERY MARKET, BY CLINICAL SETTING

8.1 OVERVIEW

8.2 URBAN NEUROSURGERY CENTERS

8.3 SUBURBAN AND REGIONAL CENTERS

8.4 REMOTE AREA CLINICS

9 AUSTRALIA NEUROSURGERY MARKET, BY TECHNOLOGY

9.1 OVERVIEW

9.2 MINIMALLY INVASIVE TOOLS

9.2.1 ENDOSCOPES

9.2.2 ROBOTIC-ASSISTED SURGICAL SYSTEMS

9.3 IMAGING SYSTEMS

9.3.1 MRI-GUIDED SYSTEMS

9.3.2 CT-GUIDED SYSTEMS

9.4 NAVIGATION SYSTEMS

9.5 INTRA-OPERATIVE ULTRASOUND SYSTEMS

9.6 OTHERS

10 AUSTRALIA NEUROSURGERY MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.3 PUBLIC

10.4 PRIVATE

10.4.1 SPECIALTY NEUROSURGERY CENTERS

10.4.2 ACADEMIC AND RESEARCH INSTITUTES

10.4.3 AMBULATORY SURGICAL CENTERS (ASCS)

11 AUSTRALIA NEUROSURGERY MARKET: COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: AUSTRALIA

12 SWOT ANALYSIS

13 COMPANY PROFILES

13.1 MEDTRONIC

13.1.1 COMPANY SNAPSHOT

13.1.2 REVENUE ANALYSIS

13.1.3 PRODUCT PORTFOLIO

13.1.4 RECENT DEVELOPMENT

13.2 INTEGRA LIFESCIENCES CORPORATION

13.2.1 COMPANY SNAPSHOT

13.2.2 REVENUE ANALYSIS

13.2.3 PRODUCT PORTFOLIO

13.2.4 RECENT DEVELOPMENT

13.3 GE HEALTHCARE

13.3.1 COMPANY SNAPSHOT

13.3.2 REVENUE ANALYSIS

13.3.3 PRODUCT PORTFOLIO

13.3.4 RECENT DEVELOPMENT

13.4 SIEMENS HEALTHINEERS AG

13.4.1 COMPANY SNAPSHOT

13.4.2 REVENUE ANALYSIS

13.4.3 PRODUCT PORTFOLIO

13.4.4 RECENT DEVELOPMENT

13.5 STRYKER

13.5.1 COMPANY SNAPSHOT

13.5.2 REVENUE ANALYSIS

13.5.3 PRODUCT PORTFOLIO

13.5.4 RECENT DEVELOPMENT

13.6 BRAINLAB AG

13.6.1 COMPANY SNAPSHOT

13.6.2 PRODUCT PORTFOLIO

13.6.3 RECENT DEVELOPMENT

13.7 ELEKTA

13.7.1 COMPANY SNAPSHOT

13.7.2 REVENUE ANALYSIS

13.7.3 PRODUCT PORTFOLIO

13.7.4 RECENT DEVELOPMENT

13.8 FUJIFILM HOLDINGS CORPORATION

13.8.1 COMPANY SNAPSHOT

13.8.2 REVENUE ANALYSIS

13.8.3 PRODUCT PORTFOLIO

13.8.4 RECENT DEVELOPMENT

13.9 SYNAPTIVE MEDICAL

13.9.1 COMPANY SNAPSHOT

13.9.2 PRODUCT PORTFOLIO

13.9.3 RECENT DEVELOPMENT

13.1 ZIMMER BIOMET

13.10.1 COMPANY SNAPSHOT

13.10.2 REVENUE ANALYSIS

13.10.3 PRODUCT PORTFOLIO

13.10.4 RECENT DEVELOPMENT

14 QUESTIONNAIRE

15 RELATED REPORTS